Join to View Full Profile
111 Michigan Ave NWSte 100Washington, DC 20010
Phone+1 202-476-6151
Fax+1 202-476-3850
Dr. Viswanathan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Prabha Viswanathan is a specialist in Pediatric Infectious Disease based in Washington, DC. She completed her fellowship in Pediatric Infectious Diseases at Children's National Hospital/George Washington University from 2010 to 2013, following a medical degree from the University of Kansas School of Medicine in 2003 and a residency in Pediatrics at the Children's Hospital of Philadelphia from 2003 to 2006. Her publication record includes articles on antiretroviral regimens during pregnancy and the pharmacokinetics of lamivudine, reflecting her involvement in both clinical and regulatory aspects of pediatric infectious disease treatments.
Education & Training
Children's National Hospital/George Washington UniversityFellowship, Pediatric Infectious Diseases, 2010 - 2013
Children's Hospital of PhiladelphiaResidency, Pediatrics, 2003 - 2006
University of Kansas School of MedicineClass of 2003
Certifications & Licensure
DC State Medical License 2010 - 2027
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Infectious Diseases
Publications & Presentations
PubMed
- Clinical fellowship augmented by regulatory review experience: a perspective on the Children's National Hospital/FDA fellowship tracks.Jency Daniel, Nicholas Geagan, Nada Harik, Debra Birnkrant, Ramya Gopinath
Proceedings. 2024-01-01 - 28 citationsCobicistat-containing antiretroviral regimens are not recommended during pregnancy: viewpoint.Sarita D. Boyd, Mario R Sampson, Prabha Viswanathan, Kimberly A Struble, Vikram Arya
AIDS. 2019-05-01 - 3 citationsEffects of Sorbitol on the Pharmacokinetics of Lamivudine Solution and the FDA's Decision to Increase the Dose of Lamivudine Solution for Pediatric Patients.Su-Young Choi, Prabha Viswanathan, Adam Sherwat, Shirley Seo
Clinical Pharmacology and Therapeutics. 2018-11-01
Journal Articles
- Effects of Sorbitol on the Pharmacokinetics of Lamivudine Solution and the FDA's Decision to Increase the Dose of Lamivudine Solution for Pediatric PatientsPrabha Viswanathan, MD, Clinical Pharmacology & Therapeutics
Press Mentions
- Schools Should Normalize Pauses for Coronavirus SafetyJanuary 25th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
